We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIK icon
976
Anika Therapeutics
ANIK
$257M
$185K ﹤0.01%
+17,500
New +$221K
BWEN icon
977
Broadwind
BWEN
$106M
$185K ﹤0.01%
102,221
+4,903
+5% +$8.27K
RRGB icon
978
Red Robin
RRGB
$151M
$184K ﹤0.01%
31,700
TARA icon
979
Protara Therapeutics
TARA
$225M
$181K ﹤0.01%
59,830
+19,830
+50% +$68.4K
FUSB icon
980
First US Bancshares
FUSB
$92.1M
$181K ﹤0.01%
14,040
+441
+3% +$5.65K
KLXE icon
981
KLX Energy Services
KLXE
$42.1M
$181K ﹤0.01%
96,574
KTCC icon
982
Key Tronic
KTCC
$44.2M
$178K ﹤0.01%
62,200
SCOR icon
983
Comscore
SCOR
$114M
$177K ﹤0.01%
36,772
HAPN
984
Happen Inc
HAPN
$2.36B
$176K ﹤0.01%
14,648
-207
-1% -$2.15K
XBIT icon
985
XBiotech
XBIT
$68.9M
$176K ﹤0.01%
59,326
-63,706
-52% -$185K
BRID icon
986
Bridgford Foods
BRID
$56.5M
$176K ﹤0.01%
22,300
SKYE icon
987
Skye Bioscience
SKYE
$19.7M
$176K ﹤0.01%
42,000
TAIT
988
DELISTED
Taitron Components
TAIT
$175K ﹤0.01%
78,200
ZDGE icon
989
Zedge
ZDGE
$38.8M
$175K ﹤0.01%
43,655
HYLN icon
990
Hyliion Holdings
HYLN
$703M
$175K ﹤0.01%
132,500
+90,000
+212% +$131K
NEOV icon
991
NeoVolta
NEOV
$158M
$172K ﹤0.01%
52,200
AREN icon
992
Arena Group
AREN
$71.9M
$171K ﹤0.01%
27,600
-15,000
-35% -$73.7K
LUNG icon
993
Pulmonx
LUNG
$83.6M
$170K ﹤0.01%
65,800
NTWK icon
994
NetSol Technologies
NTWK
$50.8M
$167K ﹤0.01%
53,708
+4,816
+10% +$12.7K
PASG icon
995
Passage Bio
PASG
$14.8M
$167K ﹤0.01%
20,802
-4,505
-18% -$32.9K
CLYM
996
Climb Bio
CLYM
$714M
$167K ﹤0.01%
134,300
INSG icon
997
Inseego
INSG
$121M
$166K ﹤0.01%
20,100
-10,000
-33% -$78.2K
AMLX icon
998
Amylyx Pharmaceuticals
AMLX
$2.43B
$165K ﹤0.01%
25,700
-130,000
-83% -$632K
CLSD
999
DELISTED
Clearside Biomedical
CLSD
$164K ﹤0.01%
13,667
-3,333
-20% -$41.4K
ACCS
1000
ACCESS Newswire
ACCS
$26.7M
$163K ﹤0.01%
13,268

Similar funds

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.